Physician profile
Lance Johnson
NPI 1174058630
$9,642.88
in general payments reported to CMS, 2019-2025
19 companies · $410 in 2025
The $410 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $726 · 2021: $5,192 · 2022: $2,548 · 2023: $421 · 2024: $225 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,056.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,056.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,055.05 | 2021 | |
| Rock Medical Orthopedics, INC. | $2,400.00 | 2022 | |
| Stryker Corporation | $1,177.72 | 2020-2025 | Augment Injectable, Hoffmann |
| Restor3d, INC. | $1,108.00 | 2021 | |
| Integra Lifesciences Corporation | $636.41 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Dne LLC | $255.20 | 2020 | |
| Access Pro Medical, LLC | $153.43 | 2025 | Matriderm |
| Smith+Nephew, INC. | $152.03 | 2020-2025 | Renasys Go V2 Home, Grafix Pl |
| Bioventus LLC | $131.73 | 2022 | |
| Paragon 28, INC. | $121.91 | 2023 | Portfolio |
| Pacira Pharmaceuticals Incorporated | $119.99 | 2019 | |
| Kerecis Limited | $113.28 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Medshape, INC. | $63.84 | 2020 | |
| Mimedx Group, INC. | $51.43 | 2025 | |
| Organogenesis INC. | $41.47 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $20.05 | 2020 | |
| Polynovo North America LLC | $18.99 | 2025 | Novosorb Btm |
| Acell, INC. | $14.86 | 2020 | |
| Lifenet Health | $7.49 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.